Alexandros Makriyannis, George D. Behrakis Endowed Chair at Northeastern and Founder and Director of the Center for Drug Discovery, has received the American Association of Pharmaceutical Scientists Distinguished Pharmaceutical Scientist Award for 2015. This award is part of a long line of accomplishments for Makriyannis, who has published over 500 papers and has over 50 patents in the field of medicinal chemistry.
The seventh row of the periodic table is now complete after Monday’s announcement of four new elements. Chemistry professor Michael Pollastri explains why this is an important milestone for science.
Two professors – one from the biology department and the other from the chemistry and chemical biology department – have been awarded more than a half-million dollars to investigate the production of cancer drugs in Catharanthus roseus.
Thirty students took part in NU-CD4. The course focused on the drug development process and gave the students the opportunity both to visit world-leading institutions in pharmaceutical research and manufacturing and conduct a research project focusing on identifying problems with existing drugs and developing novel remedies for those problems.
Professor Matthias Mann, Director in the Department of Proteomics and Signal Transduction at the Max Planck Institute of Biochemistry in Munich, Germany, was the recipient the Inaugural Barry L. Karger Medal in Bioanalysis.
James Aggen, a professor in the College of Science and Bouve College of Health Sciences, describes his to work to develop antidotes for multidrug-resistant (MDR) Gram-negative bacterial infections.
Northeastern’s chemistry department was recently ranked in the top 10 in a review of career support services among American chemistry departments.
The prevailing view of research science is that professors and laboratory staff work on obscure challenges for which a lifetime might not be enough time to solve. Or that their projects might have limited application in the ‘real’ world. If that’s how you think, you haven’t met Dr. Barry Karger.
Dr. William Hancock, the Bradstreet Chair in Chemistry and Chemical Biology and an expert in protein drugs, has been invited to serve as a consultant as a consultant to the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA).
by Emily Ashbolt, Biomedical Physics, 2017 For the past decade, Northeastern University Chemistry and Chemical Biology professor Penny Beuning has focused her research on cellular responses to DNA damage, specifically a family of DNA polymerases that deal with copying the damaged DNA. Her tireless work in this area of chemistry has earned her the Chemical Research […]